Search results
Market Today: Pfizer Pauses Gene Therapy Trial After Patient Dea
Guru Focus· 16 minutes agoThe stock market exhibited mixed results at the close today. The Nasdaq Composite edged down by...
Pfizer pauses phase 3 dosing in gene therapy trial after young boy's death
FierceBiotech· 3 hours agoA young boy with Duchenne muscular dystrophy (DMD) participating in Pfizer’s phase 2 gene therapy...
Pfizer Pauses Gene Therapy Trial for Muscle Disease After Death
Bloomberg· 3 hours agoPfizer Inc. paused a study of an experimental gene therapy for muscular dystrophy after a child who...
Pfizer reports patient death in Duchenne gene therapy study
KFGO· 58 minutes ago(Reuters) - A young boy died due to a cardiac arrest in a mid-stage trial that tested Pfizer's...
Pfizer wants the $75 mln left from SAC Capital’s insider trading settlement with SEC
Reuters· 3 hours agoPharma company Pfizer told a New York federal judge on Monday that it is entitled to recoup about...
Patient dies in Pfizer study of Duchenne gene therapy
BioPharma Dive via Yahoo Finance· 6 hours agoPfizer said the patient, a young boy who was treated earlier last year, had died suddenly. The...
Pfizer First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 12 hours agoPfizer (NYSE:PFE) First Quarter 2024 Results Key Financial Results Revenue: US$14.9b (down 19% from...
AstraZeneca withdrawing Covid vaccine, months after admitting rare side effect
The Telegraph via Yahoo News· 3 hours agoThe Oxford-AstraZeneca Covid vaccine is being withdrawn worldwide, months after the pharmaceutical...
Is Pfizer Stock Fully Valued At $28?
Forbes· 18 hours agoPfizer (NYSE: PFE) reported its Q1 results last week, with revenues and earnings beating the street estimates.
Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know
Zacks via Yahoo Finance· 1 day agoPfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to...